Likely damaging de novo variants in congenital diaphragmatic hernia patients are associated with worse clinical outcomes

Lu Qiao, Julia Wynn, Lan Yu, Rebecca Hernan, Xueya Zhou, Vincent Duron, Gudrun Aspelund, Christiana Farkouh-Karoleski, Annette Zygumunt, Usha S Krishnan, Shannon Nees, Julie Khlevner, Foong Yen Lim, Timothy Crombleholme, Robert Cusick, Kenneth Azarow, Melissa Ellen Danko, Dai Chung, Brad W Warner, George B Mychaliska, Douglas Potoka, Amy J Wagner, Samuel Soffer, David Schindel, David J McCulley, Yufeng Shen, Wendy K Chung, Lu Qiao, Julia Wynn, Lan Yu, Rebecca Hernan, Xueya Zhou, Vincent Duron, Gudrun Aspelund, Christiana Farkouh-Karoleski, Annette Zygumunt, Usha S Krishnan, Shannon Nees, Julie Khlevner, Foong Yen Lim, Timothy Crombleholme, Robert Cusick, Kenneth Azarow, Melissa Ellen Danko, Dai Chung, Brad W Warner, George B Mychaliska, Douglas Potoka, Amy J Wagner, Samuel Soffer, David Schindel, David J McCulley, Yufeng Shen, Wendy K Chung

Abstract

Purpose: Congenital diaphragmatic hernia (CDH) is associated with significant mortality and long-term morbidity in some but not all individuals. We hypothesize monogenic factors that cause CDH are likely to have pleiotropic effects and be associated with worse clinical outcomes.

Methods: We enrolled and prospectively followed 647 newborns with CDH and performed genomic sequencing on 462 trios to identify de novo variants. We grouped cases into those with and without likely damaging (LD) variants and systematically assessed CDH clinical outcomes between the genetic groups.

Results: Complex cases with additional congenital anomalies had higher mortality than isolated cases (P = 8 × 10-6). Isolated cases with LD variants had similar mortality to complex cases and much higher mortality than isolated cases without LD (P = 3 × 10-3). The trend was similar with pulmonary hypertension at 1 month. Cases with LD variants had an estimated 12-17 points lower scores on neurodevelopmental assessments at 2 years compared with cases without LD variants, and this difference is similar in isolated and complex cases.

Conclusion: We found that the LD genetic variants are associated with higher mortality, worse pulmonary hypertension, and worse neurodevelopment outcomes compared with non-LD variants. Our results have important implications for prognosis, potential intervention and long-term follow up for children with CDH.

Keywords: congenital diaphragmatic hernia; de novo variants; mortality of birth defects; neurodevelopmental outcome; pleiotropic.

Conflict of interest statement

Conflict of interest

All authors declare no conflicts of interest.

Figures

Figure 1.. Study design and number of…
Figure 1.. Study design and number of patients.
PH: pulmonary hypertension; 2yr: 2 years of age; BSID-III: Bayley Scales of Infant Development third edition; VABS-II: Vineland Adaptive Behavior Scales second edition.
Figure 2.. Association analyses for genetic groups…
Figure 2.. Association analyses for genetic groups with mortality and pulmonary hypertension.
(A) Mortality prior to initial discharge. (B) Pulmonary hypertension at 1 month. (C) Pulmonary hypertension at 3 months. P value is given by Fisher’s exact test after correcting multiple tests (P<5×10−3). **: P<0.001; *: P<0.005”.
Figure 3.. Association analyses for genetic groups…
Figure 3.. Association analyses for genetic groups with neurodevelopmental outcomes at 2 years of age.
(A) BSID-III language, (B) BSID-III cognition, (C) BSID-III motor, (D) VABS-II composite adaptive behavior. The black line in the middle of the box is the mean value for each group. The vertical size of the box is the interquartile range (IQR). The whisker is 1.5xIQR. P value is given by Student’s t-test with bold as significant after correcting multiple tests (P<5×10−3).
Figure 4.. Effect size for likely damaging…
Figure 4.. Effect size for likely damaging variants on neurodevelopmental outcomes at 2yr comparing to non-LD variants.
(A) BSID-III language, (B) BSID-III cognitive, (C) BSID-III motor, (D) VABS-II composite adaptive behavior. Effect size is the coefficient/beta, which aligns with outcome on the y-axis, with the vertical dashed line (v=0) separating positive and negative direction of association. Significant P value after correcting multiple tests (P<5×10−3) is noted. LD: likely damaging variants; SES: socioeconomic status; PH: pulmonary hypertension; ECMO: extracorporeal membrane oxygenation.

References

    1. Yu L, Hernan RR, Wynn J, Chung WK. The influence of genetics in congenital diaphragmatic hernia. Seminars in perinatology. 2019:151169.
    1. Kammoun M, Souche E, Brady P, et al. Genetic profile of isolated congenital diaphragmatic hernia revealed by targeted next-generation sequencing. Prenat Diagn. 2018;38(9):654–663.
    1. Slavotinek AM. The genetics of common disorders - congenital diaphragmatic hernia. Eur J Med Genet. 2014;57(8):418–423.
    1. Pober BR, Lin A, Russell M, et al. Infants with Bochdalek diaphragmatic hernia: sibling precurrence and monozygotic twin discordance in a hospital-based malformation surveillance program. Am J Med Genet A. 2005;138A(2):81–88.
    1. Yu L, Wynn J, Ma L, et al. De novo copy number variants are associated with congenital diaphragmatic hernia. J Med Genet. 2012;49(10):650–659.
    1. Qi H, Yu L, Zhou X, et al. De novo variants in congenital diaphragmatic hernia identify MYRF as a new syndrome and reveal genetic overlaps with other developmental disorders. PLoS genetics. 2018;14(12):e1007822.
    1. Zhu Q, High FA, Zhang C, et al. Systematic analysis of copy number variation associated with congenital diaphragmatic hernia. Proceedings of the National Academy of Sciences of the United States of America. 2018;115(20):5247–5252.
    1. Yu L, Sawle AD, Wynn J, et al. Increased burden of de novo predicted deleterious variants in complex congenital diaphragmatic hernia. Hum Mol Genet. 2015;24(16):4764–4773.
    1. Wynn J, Aspelund G, Zygmunt A, et al. Developmental outcomes of children with congenital diaphragmatic hernia: a multicenter prospective study. J Pediatr Surg. 2013;48(10):1995–2004.
    1. Wynn J, Krishnan U, Aspelund G, et al. Outcomes of congenital diaphragmatic hernia in the modern era of management. J Pediatr. 2013;163(1):114–119 e111.
    1. Homsy J, Zaidi S, Shen Y, et al. De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies. Science. 2015;350(6265):1262–1266.
    1. Jin SC, Homsy J, Zaidi S, et al. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat Genet. 2017;49(11):1593–1601.
    1. Farkouh-Karoleski C, Najaf T, Wynn J, et al. A definition of gentle ventilation in congenital diaphragmatic hernia: a survey of neonatologists and pediatric surgeons. J Perinat Med. 2017;45(9):1031–1038.
    1. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
    1. Hollingshead A Four Factor Index of Social Status. 2011;Yale Journal of Sociology(8):21–51.
    1. Bayley N Bayley Scales of Infant and Toddler Development-Third Edition. TX: Hartcourt Assessments, Inc, San Antonio: 2006.
    1. Harrison PL, Oakland T. Adaptive behavior assessment system (2nd ed.). San Antonio: Harcourt; 2003.
    1. Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886–D894.
    1. Abyzov A, Urban AE, Snyder M, Gerstein M. CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. Genome Res. 2011;21(6):974–984.
    1. Layer RM, Chiang C, Quinlan AR, Hall IM. LUMPY: a probabilistic framework for structural variant discovery. Genome Biol. 2014;15(6):R84.
    1. Chiang C, Layer RM, Faust GG, et al. SpeedSeq: ultra-fast personal genome analysis and interpretation. Nat Methods. 2015;12(10):966–968.
    1. Samocha KE, Robinson EB, Sanders SJ, et al. A framework for the interpretation of de novo mutation in human disease. Nat Genet. 2014;46(9):944–950.
    1. Riggs ER, Church DM, Hanson K, et al. Towards an evidence-based process for the clinical interpretation of copy number variation. Clin Genet. 2012;81(5):403–412.
    1. Werling DM, Brand H, An JY, et al. An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder. Nat Genet. 2018;50(5):727–736.
    1. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet. 2004;74(4):765–769.
    1. Santosa F, Symes WW. Linear Inversion of Band-Limited Reflection Seismograms. SIAM Journal on Scientific and Statistical Computing. 1986;7(4):1307–1330.
    1. Tibshirani R Regression Shrinkage and Selection via the Lasso. Journal of the Royal Statistical Society. 1996;58(1):267–288.
    1. Longoni M, High FA, Qi H, et al. Genome-wide enrichment of damaging de novo variants in patients with isolated and complex congenital diaphragmatic hernia. Hum Genet. 2017;136(6):679–691.
    1. Mous DS, Kool HM, Wijnen R, Tibboel D, Rottier RJ. Pulmonary vascular development in congenital diaphragmatic hernia. Eur Respir Rev. 2018;27(147).
    1. Sluiter I, van der Horst I, van der Voorn P, et al. Premature differentiation of vascular smooth muscle cells in human congenital diaphragmatic hernia. Exp Mol Pathol. 2013;94(1):195–202.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere